FOX RUN MANAGEMENT, L.L.C. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
FOX RUN MANAGEMENT, L.L.C. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2023$1,194,514
+20.7%
14,030
+11.5%
0.34%
-15.4%
Q4 2022$989,574
+371.2%
12,582
+566.1%
0.40%
+4.7%
Q1 2021$210,000
-71.6%
1,889
-70.7%
0.38%
-36.4%
Q4 2019$740,000
+80.5%
6,441
+40.8%
0.60%
+358.5%
Q2 2018$410,000
+78.3%
4,573
+45.5%
0.13%
+132.1%
Q1 2018$230,000
-39.9%
3,142
-67.6%
0.06%
-57.6%
Q2 2017$383,000
+60.9%
9,700
+18.3%
0.13%
+13.8%
Q2 2016$238,000
-13.8%
8,200
+3.8%
0.12%
-37.0%
Q1 2016$276,0007,9000.18%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders